| |
| |
|
| Insider
Information: |
Galakatos Nicholas |
| Relationship: |
Director, 10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
24,434 |
|
|
Indirect Shares
|
17,952,130 |
|
|
| Direct
Value |
$227,089 |
|
|
|
Indirect Value
|
$87,036,939 |
|
|
| Total
Shares |
17,976,564 |
|
|
| Total
Value |
$87,264,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-07-02 |
0 |
2004-07-02 |
1,833,597 |
Premium* |
|
|
Affymax Inc |
AFFY |
Director, 10% Owner |
2006-12-20 |
18,750 |
2006-12-20 |
1,600,469 |
Premium* |
|
|
Ithaka Acquisition Corp |
ITHKU |
10% Owner |
|
0 |
2007-06-21 |
2,672,568 |
Premium* |
|
|
American Cryostem Corporation |
CRYO |
10% Owner |
2007-04-24 |
0 |
2008-05-28 |
0 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2010-03-17 |
0 |
2010-03-17 |
2,208,961 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-06-10 |
0 |
2014-06-10 |
1,220,672 |
Premium* |
|
|
Nanostring Technologies Inc |
NSTG |
Director, 10% Owner |
2013-07-01 |
0 |
2018-09-17 |
4,036,025 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
Director |
2016-01-11 |
5,684 |
2016-01-11 |
3,945 |
Premium* |
|
|
Astria Therapeutics, Inc |
ATXS |
Director, 10% Owner |
2015-06-30 |
0 |
2015-06-30 |
2,752,488 |
Premium* |
|
|
Entasis Therapeutics Holdings Inc. |
ETTX |
Director, 10% Owner |
2018-09-28 |
0 |
2018-09-28 |
1,623,405 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ETTX |
Entasis Therapeutics Hold... |
Director |
– • • |
2018-09-28 |
4 |
B |
$15.00 |
$6,800,925 |
I/I |
453,395 |
1,623,405 |
2.25 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
Director |
– • • |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,097,753 |
1,170,010 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Director |
– • • |
2018-09-17 |
4 |
S |
$15.99 |
$1,372,310 |
I/I |
(85,823) |
4,036,025 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Director |
– • • |
2018-09-17 |
4 |
OE |
$8.45 |
$1,372,023 |
I/I |
162,408 |
4,121,848 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2016-01-11 |
4 |
AS |
$65.33 |
$65,390 |
I/I |
(1,000) |
3,945 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2016-01-11 |
4 |
AS |
$65.45 |
$131,781 |
D/D |
(2,000) |
5,684 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-12-10 |
4 |
AS |
$63.91 |
$64,438 |
I/I |
(1,000) |
4,945 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-12-10 |
4 |
AS |
$63.90 |
$128,871 |
D/D |
(2,000) |
7,684 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-18 |
4 |
AS |
$60.00 |
$60,000 |
D/D |
(1,000) |
9,684 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-18 |
4 |
AS |
$60.00 |
$30,000 |
I/I |
(500) |
5,945 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-10 |
4 |
AS |
$58.69 |
$29,345 |
I/I |
(500) |
6,445 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-10 |
4 |
AS |
$58.69 |
$58,690 |
D/D |
(1,000) |
10,684 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-09 |
4 |
AS |
$60.00 |
$30,000 |
I/I |
(500) |
6,945 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-09 |
4 |
AS |
$60.00 |
$60,000 |
D/D |
(1,000) |
11,684 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-02 |
4 |
AS |
$54.00 |
$27,000 |
I/I |
(500) |
7,445 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-11-02 |
4 |
AS |
$54.00 |
$54,000 |
D/D |
(1,000) |
13,184 |
0 |
- |
|
| ATXS |
Astria Therapeutics, Inc |
Director |
– • • |
2015-06-30 |
4 |
B |
$12.00 |
$4,520,340 |
I/I |
376,695 |
2,752,488 |
2.25 |
- |
|
| ATXS |
Astria Therapeutics, Inc |
Director |
– • • |
2015-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,375,793 |
2,375,793 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-06-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,020 |
14,184 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-05-26 |
4 |
A |
$0.00 |
$0 |
I/I |
3,137 |
7,945 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,319 |
15,204 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2015-05-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,554,744) |
0 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2014-06-16 |
4 |
S |
$44.00 |
$681,208 |
I/I |
(15,482) |
2,698,588 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2014-06-16 |
4 |
D |
$44.24 |
$50,602,515 |
I/I |
(1,143,844) |
1,554,744 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2014-06-16 |
4 |
A |
$44.24 |
$238,227 |
D/D |
5,385 |
7,885 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
